| CTRI Number |
CTRI/2025/07/090014 [Registered on: 02/07/2025] Trial Registered Prospectively |
| Last Modified On: |
30/06/2025 |
| Post Graduate Thesis |
Yes |
| Type of Trial |
Interventional |
|
Type of Study
|
Drug Ayurveda |
| Study Design |
Randomized, Parallel Group Trial |
|
Public Title of Study
|
A Comparative Clinical Study on the Effectiveness of Kantakari kwath mouth rinse and Triphaladi Kwath mouth rinse in the Treatment of Dental Caries in age group 18-50 years |
|
Scientific Title of Study
|
Randomized controlled clinical trial to compare efficacy of kantakari kwath gandush and triphaladi kwath gandush in the management of krimidant. |
| Trial Acronym |
NIL |
|
Secondary IDs if Any
|
| Secondary ID |
Identifier |
| NIL |
NIL |
|
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
| Name |
Dr Prajakta Prabhakar Ingale |
| Designation |
PG Scholar |
| Affiliation |
Tilak Ayurved Mahavidyalaya pune |
| Address |
Department of Shalakyatantra Tilak Ayurved Mahavidyalaya pune
Pune MAHARASHTRA 411011 India |
| Phone |
7391961956 |
| Fax |
|
| Email |
prajaktaingale789@gmail.com |
|
Details of Contact Person Scientific Query
|
| Name |
Dr Sangeeta Santosh Salvi |
| Designation |
Head of Department |
| Affiliation |
Tilak Ayurved Mahavidyalaya pune |
| Address |
Department of Shalakyatantra Tilak Ayurved Mahavidyalaya pune
Pune MAHARASHTRA 411011 India |
| Phone |
09822082795 |
| Fax |
|
| Email |
salvisangeeta@yahoo.co.in |
|
Details of Contact Person Public Query
|
| Name |
Dr Sangeeta santosh Salvi |
| Designation |
Head of department |
| Affiliation |
Tilak Ayurved Mahavidyalaya pune |
| Address |
Department of Shalakyatantra Tilak Ayurved Mahavidyalaya pune
Pune MAHARASHTRA 411011 India |
| Phone |
09822082795 |
| Fax |
|
| Email |
salvisangeeta@yahoo.co.in |
|
|
Source of Monetary or Material Support
|
| Seth Tarachand Ramnath Charitable Ayurvedic Hospital, 580/2 Rasta Peth, Pune, 411011,
Maharashtra, India. |
|
|
Primary Sponsor
|
| Name |
TILAK AYURVED MAHAVIDYALAYA |
| Address |
Tilak Ayurved
Mahavidyalaya, 2nd floor,
shalakyatantra
department, Rastapeth,
583/2, Pune 411011.
Pune MAHARASHTRA |
| Type of Sponsor |
Private medical college |
|
|
Details of Secondary Sponsor
|
|
|
Countries of Recruitment
|
India |
|
Sites of Study
|
| No of Sites = 1 |
| Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
| Dr Prajakta Ingale |
Seth Tarachand Ramnath Ayurvedic Hospital Pune |
Tilak Ayurved Mahavidyalaya, 2nd floor, Shalakyatantra department, Rastapeth, 583/2, Pune 411011. Pune MAHARASHTRA Pune MAHARASHTRA
Pune
MAHARASHTRA Pune MAHARASHTRA |
07391961956
prajaktaingale789@gmail.com |
|
|
Details of Ethics Committee
|
| No of Ethics Committees= 1 |
| Name of Committee |
Approval Status |
| Instituitional ethical committe, TAMV pune |
Approved |
|
|
Regulatory Clearance Status from DCGI
|
|
|
Health Condition / Problems Studied
|
| Health Type |
Condition |
| Patients |
(1) ICD-10 Condition:K029||Dental caries, unspecified. Ayurveda Condition: KRUMIDANTAKAH, |
|
|
Intervention / Comparator Agent
|
| sno | Intervention/Comparator | Type | Drug-Type | Procedure Name | Details | | 1 | Intervention Arm | Drug | Classical | | (1) Medicine Name: Kantakari Kwatha, Reference: Bhaishajyaratnavali .chikitsasthana 61th adhyaya Mukharogachikitsa adhyaya Shlok number 41, Route: Topical, Dosage Form: Kwatha/ Kashaya, Dose: 80(ml), Frequency: tds, Bhaishajya Kal: Adhobhakta, Duration: 7 Days, anupAna/sahapAna: No, Additional Information: - | | 2 | Comparator Arm | Drug | Other than Classical | | (1) Medicine Name: Triphaladi Kwatha, Reference: NA, Route: Topical, Dosage Form: Kwatha/Kashaya, Dose: 80(ml), Frequency: tds, Bhaishajya Kal: Adhobhakta, Duration: 7 Days, anupAna/sahapAna: No, Additional Information: - |
|
|
|
Inclusion Criteria
|
| Age From |
18.00 Year(s) |
| Age To |
50.00 Year(s) |
| Gender |
Both |
| Details |
1. Participants with features of black discoloration of teeth, pain and swelling of gum.
2. Freshly infected.
3. 1 – 4 teeth infected |
|
| ExclusionCriteria |
| Details |
1. Participants having history of other disease of oral cavity like oral malignancy, stomatitis.
2. Participant having history of fractured tooth, periodontal abscess. |
|
|
Method of Generating Random Sequence
|
Coin toss, Lottery, toss of dice, shuffling cards etc |
|
Method of Concealment
|
Alternation |
|
Blinding/Masking
|
Not Applicable |
|
Primary Outcome
|
| Outcome |
TimePoints |
| decrease in pain and discolouration |
3 day |
|
|
Secondary Outcome
|
| Outcome |
TimePoints |
| decrease in pain , discolouration and inflammation of gums |
7 day |
|
|
Target Sample Size
|
Total Sample Size="70" Sample Size from India="70"
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" |
|
Phase of Trial
|
Phase 2/ Phase 3 |
|
Date of First Enrollment (India)
|
30/07/2025 |
| Date of Study Completion (India) |
Applicable only for Completed/Terminated trials |
| Date of First Enrollment (Global) |
Date Missing |
| Date of Study Completion (Global) |
Applicable only for Completed/Terminated trials |
|
Estimated Duration of Trial
|
Years="1" Months="6" Days="0" |
|
Recruitment Status of Trial (Global)
|
Not Yet Recruiting |
| Recruitment Status of Trial (India) |
Not Yet Recruiting |
|
Publication Details
|
N/A |
|
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
Response - NO
|
|
Brief Summary
|
The study will be intervened by the treatment of Kantakari kwatha gandusha and Triphaladi Kwatha Gandusha to group A and group B respectively. The efficacy of the therapy will be assessed on the basis of subjective and objective criteria for statistical analysis. Scoring will be designed according to the severity of symptoms. The subjective and objective gradation of symptoms will be done as follows and the intensity of each symptom will be calculated before treatment, after treatment and after follow up. The effect of treatment result will be assessed in regards to clinical signs and symptoms on the basis of grading and scoring system. The signs and symptoms will be assessed by adopting the suitable scoring method. |